These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro Treatment of a Murine Mammary Adenocarcinoma Cell Line with Recombinant Trypanosoma cruzi Calreticulin Promotes Immunogenicity and Phagocytosis. Sosoniuk-Roche E; Cruz P; Maldonado I; Duaso L; Pesce B; Michalak M; Valck C; Ferreira A Mol Immunol; 2020 Aug; 124():51-60. PubMed ID: 32526557 [TBL] [Abstract][Full Text] [Related]
4. Human survivin and Trypanosoma cruzi calreticulin act in synergy against a murine melanoma in vivo. Aguilar-Guzmán L; Lobos-González L; Rosas C; Vallejos G; Falcón C; Sosoniuk E; Coddou F; Leyton L; Lemus D; Quest AF; Ferreira A PLoS One; 2014; 9(4):e95457. PubMed ID: 24755644 [TBL] [Abstract][Full Text] [Related]
5. F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement. Aguilar L; Ramírez G; Valck C; Molina MC; Rojas A; Schwaeble W; Ferreira V; Ferreira A Biol Res; 2005; 38(2-3):187-95. PubMed ID: 16238097 [TBL] [Abstract][Full Text] [Related]
6. Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth. Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Abello P; Ferreira A Front Oncol; 2014; 4():382. PubMed ID: 25629005 [TBL] [Abstract][Full Text] [Related]
7. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta. Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898 [TBL] [Abstract][Full Text] [Related]
17. Ramírez-Toloza G; Ferreira A Front Microbiol; 2017; 8():1667. PubMed ID: 28919885 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens. Toledo V; Ramírez G; Valck C; López N; Ribeiro CH; Maldonado I; Aguilar L; Lemus D; Ferreira A Biol Res; 2010; 43(3):287-9. PubMed ID: 21249299 [TBL] [Abstract][Full Text] [Related]
19. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge. Sánchez-Valdéz FJ; Pérez Brandán C; Ramírez G; Uncos AD; Zago MP; Cimino RO; Cardozo RM; Marco JD; Ferreira A; Basombrío MÁ PLoS Negl Trop Dis; 2014 Feb; 8(2):e2696. PubMed ID: 24551259 [TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection. Johnson CA; Kleshchenko YY; Ikejiani AO; Udoko AN; Cardenas TC; Pratap S; Duquette MA; Lima MF; Lawler J; Villalta F; Nde PN PLoS One; 2012; 7(7):e40614. PubMed ID: 22808206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]